Timonium, MD, United States of America

Robert Deans

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Mesoblast International Sarl. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Deans. Retrieved from https://idiyas.com/inventor/robert-deans-yh47h8bx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert Deans

Introduction

Robert Deans is an accomplished inventor based in Timonium, MD (US). He holds two patents that showcase his contributions to the field of joint repair. His innovative methods focus on utilizing mesenchymal stem cells to enhance the healing process of joints.

Latest Patents

One of Robert Deans' latest patents is titled "Joint repair using mesenchymal stem cells." This method involves administering mesenchymal stem cells to a joint, which aids in the regeneration of cartilaginous tissue, including meniscal tissue. This groundbreaking approach offers new possibilities for patients suffering from joint-related issues.

Career Highlights

Throughout his career, Robert Deans has made significant strides in the medical field, particularly in joint repair technologies. His work has the potential to improve the quality of life for many individuals facing joint deterioration.

Collaborations

Robert has collaborated with notable professionals in his field, including Francis Peter Barry and J Mary Murphy. These partnerships have likely contributed to the advancement of his innovative methods and patents.

Conclusion

Robert Deans is a notable inventor whose work in joint repair using mesenchymal stem cells represents a significant advancement in medical technology. His contributions continue to influence the field and offer hope for improved treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…